Senior insider sale
Chief Financial Officer at ALPHA TAU MEDICAL LTD. — senior position signals high conviction
$878.7K
77.50K shares
What this filing means
LEVY RAPHI plans to sell 77.50K shares of ALPHA TAU MEDICAL LTD. valued at approximately $878.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001976408-26-000610
Officer· Chief Financial Officer
Since Mar 2026
77.50K
Shares to sell
$878.7K
Approx. market value
20K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Shares acquired upon exercise of employee stock options
Cash payment upon exercise of stock options
7/1/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Shares acquired upon exercise of employee stock options Cash payment upon exercise of stock options | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
20K
Market value
$240.0K
6/30/2026
—Completed
Units to sell
20K
Market value
$220.0K
6/25/2026
—Completed
Units to sell
17.50K
Market value
$167.1K
6/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
20K
Market value
$251.6K
7/1/2026
Total
Units
77.50K
Value
$878.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/30/2026 | 20K | $240.0K | — | Completed |
6/25/2026 | 20K | $220.0K | — | Completed |
6/23/2026 | 17.50K | $167.1K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 20K | $251.6K | Nasdaq | Planned |
| Total | 77.50K | $878.7K | ||